Skip to main content

Together we are beating cancer

Donate now

Breast cancer

Breast cancer is the most common cancer in the UK, with around 55,200 people diagnosed each year. It starts in the breast tissue, most commonly in cells lining the milk ducts. Breast cancer predominantly affects women, but men can get it too.
Showing 12 out of 632 results
Cancer Research UK logo

Cancer Research UK launches a new study today to investigate factors that influence breast density, a strong risk factor for breast cancer, in different ethnic groups. Cancer Research UK launches a new study today to investigate factors that influence breast density, a strong risk factor for breast cancer, in different ethnic groups.

by Cancer Research UK | News | 9 February 2005

9 February 2005

Cancer Research UK logo

Women should aim for half an hour's gentle exercise three times a week to aid their recovery from breast cancer, according to early results revealed at a University of Bristol conference on Exercise and Cancer Rehabilitation today. Women should aim for half an hour's gentle exercise three times a week to aid their recovery from breast cancer, according to early results revealed at a University of Bristol conference on Exercise and Cancer Rehabilitation today.

by Cancer Research UK | News | 7 October 2004

7 October 2004

Cancer Research UK logo

More affluent women are better informed and less likely to suffer from anxiety after treatment for breast cancer than less privileged women, according to a study published in this week's British Journal of Cancer1. More affluent women are better informed and less likely to suffer from anxiety after treatment for breast cancer than less privileged women, according to a study published in this week's British Journal of Cancer1.

by Cancer Research UK | News | 27 July 2004

27 July 2004

Cancer Research UK logo

Inheriting the wrong version of a gene called CHEK2 doubles a womanїs risk of developing breast cancer, Cancer Research UK scientists confirm in a major new international study published in the June edition of the American Journal of Human Genetics. Inheriting the wrong version of a gene called CHEK2 doubles a womanїs risk of developing breast cancer, Cancer Research UK scientists confirm in a major new international study published in the June edition of the American Journal of Human Genetics.

by Cancer Research UK | News | 16 May 2004

16 May 2004

Cancer Research UK logo

South Asian breast cancer patients living in Yorkshire may have higher rates of mastectomy compared with non-Asians because they present to their GPs too late, Cancer Research UK scientists reveal. South Asian breast cancer patients living in Yorkshire may have higher rates of mastectomy compared with non-Asians because they present to their GPs too late, Cancer Research UK scientists reveal.

by Cancer Research UK | News | 4 May 2004

4 May 2004

Cancer Research UK logo

A study coordinated by Cancer Research UK scientists and published in The Lancet1 has shown that pregnancies that end in miscarriage or abortion do not increase a woman's risk of developing breast cancer later in life. A study coordinated by Cancer Research UK scientists and published in The Lancet1 has shown that pregnancies that end in miscarriage or abortion do not increase a woman's risk of developing breast cancer later in life.

by Cancer Research UK | News | 26 March 2004

26 March 2004

Cancer Research UK logo

Cancer Research UK scientists have devised a user-friendly computer program, called the IBIS risk evaluator, which can give the most accurate estimate yet of a woman's chance of developing breast cancer. Cancer Research UK scientists have devised a user-friendly computer program, called the IBIS risk evaluator, which can give the most accurate estimate yet of a woman's chance of developing breast cancer.

by Cancer Research UK | News | 23 March 2004

23 March 2004

Cancer Research UK logo

Taking a breast cancer drug called exemestane after tamoxifen can substantially reduce the chance of recurrence, according to the early results of a major new trial, co-ordinated by Cancer Research UK funded groups1. Taking a breast cancer drug called exemestane after tamoxifen can substantially reduce the chance of recurrence, according to the early results of a major new trial, co-ordinated by Cancer Research UK funded groups1.

by Cancer Research UK | News | 10 March 2004

10 March 2004

Cancer Research UK logo

Cancer Research UK today secured a Europe-wide patent on the hereditary breast cancer gene BRCA2, in a move that will be welcomed by scientists across the continent. Cancer Research UK today secured a Europe-wide patent on the hereditary breast cancer gene BRCA2, in a move that will be welcomed by scientists across the continent.

by Cancer Research UK | News | 11 February 2004

11 February 2004

Cancer Research UK logo

Cancer Research UK scientists have discovered that the risk of breast cancer among South Asian Women in the UK differs according to their specific ethnic subgroup. Cancer Research UK scientists have discovered that the risk of breast cancer among South Asian Women in the UK differs according to their specific ethnic subgroup.

by Cancer Research UK | News | 6 January 2004

6 January 2004

Cancer Research UK logo

Our common evolutionary heritage with the humble nematode worm is helping unravel one of the key genetic puzzles in breast cancer, a new Cancer Research UK study1 reveals. Our common evolutionary heritage with the humble nematode worm is helping unravel one of the key genetic puzzles in breast cancer, a new Cancer Research UK study1 reveals.

by Cancer Research UK | News | 5 January 2004

5 January 2004

Cancer Research UK logo

A consortium of Cancer Research UK scientists and doctors has discovered a new gene for breast and ovarian cancer - providing a missing link in an enduring medical mystery. A consortium of Cancer Research UK scientists and doctors has discovered a new gene for breast and ovarian cancer - providing a missing link in an enduring medical mystery.

by Cancer Research UK | News | 25 November 2003

25 November 2003